PECSA

Serial Number 97251008
688

Registration Progress

Application Filed
Feb 2, 2022
Under Examination
Nov 4, 2025
Approved for Publication
Sep 9, 2025
Published for Opposition
Sep 9, 2025
Registered

Attorney Assistance

NOA E-Mailed - SOU Required
Due: May 04, 2026 99 days

Trademark Image

PECSA

Basic Information

Serial Number
97251008
Filing Date
February 2, 2022
Published for Opposition
September 9, 2025
Drawing Code
4

Status Summary

Current Status
Active
Status Code
688
Status Date
Nov 4, 2025
Application
Pending
Classes
005

Rights Holder

Bazelet Health Systems, Inc.

03
Address
Suite 100
6555 Sanger Road
Orlando, FL 32827

Ownership History

Bazelet Health Systems, Inc.

Original Applicant
03
Orlando, FL

Bazelet Health Systems, Inc.

Owner at Publication
03
Orlando, FL

Legal Representation

Attorney
Steven M Hoffberg

USPTO Deadlines

Next Deadline
99 days remaining
NOA E-Mailed - SOU Required
Due Date
May 04, 2026
Extension Available
Until November 04, 2026

Application History

18 events
Date Code Type Description Documents
Nov 4, 2025 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT Loading...
Sep 9, 2025 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Sep 9, 2025 PUBO A PUBLISHED FOR OPPOSITION Loading...
Sep 3, 2025 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Aug 8, 2025 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Aug 8, 2025 XAEC I EXAMINER'S AMENDMENT ENTERED Loading...
Aug 8, 2025 GNEN O NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED Loading...
Aug 8, 2025 GNEA F EXAMINERS AMENDMENT E-MAILED Loading...
Aug 8, 2025 CNEA R EXAMINERS AMENDMENT -WRITTEN Loading...
Nov 15, 2023 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
Nov 14, 2023 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Nov 14, 2023 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED Loading...
Aug 14, 2023 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED Loading...
Aug 14, 2023 GNRT F NON-FINAL ACTION E-MAILED Loading...
Aug 14, 2023 CNRT R NON-FINAL ACTION WRITTEN Loading...
Jul 17, 2023 DOCK D ASSIGNED TO EXAMINER Loading...
Feb 8, 2022 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Feb 5, 2022 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 005
Medicinal drinks; Medicinal herb extracts, other than essential oils; Medicinal herbal extracts for medical purposes, other than essential oils; Medicinal herbal preparations; Medicinal herbs; Medicinal herbs in dried or preserved form; Medicinal oils, other than essential oils; Medicinal tea; Anti-inflammatory preparations; Beverages containing cannabis extract, cannabigerol, cannabigerolic acid for use as a nutritional supplement; Decoctions of medicinal herb; Dietary supplement beverage for treatment of neurological diseases, seizures, inflammation, viral infection, diabetes, metabolic disorders, free radical excess; Dietary supplements also containing cannabis oil, other than essential oils; full spectrum cannabis herb extract in the nature of concentrated components of cannabis plant for medical purposes, other than essential oils; Dietary supplements consisting primarily of cannabis oil, other than essential oils; Dietary supplements for human beings; Dietary supplements for human consumption; Dietary supplements for treatment of insomnia, sleep disorders, depression, anxiety, neurodegenerative diseases, Alzheimer's disease, dementia, Parkinson's disease, post traumatic stress disorder, phobias, addictions, attention deficit hyperactivity disorder, autism, mood disorders, brain disorders, central nervous system disorders; Dietary supplements in the form of cannabis extract oil, other than essential oils, for medical purposes; Dietary and nutritional supplements containing panakeia extract in the nature of powder, oil and solution for medical purposes, other than essential oils; Dietary beverage supplements for human consumption in liquid and dry mix form for therapeutic purposes; Dietary fiber for treating constipation; Dietary fiber for use as an ingredient in the manufacture of dietary supplements; Dietary food supplements; Dietary supplements; Dietary supplements for humans; Food supplements for treatment of neurological diseases, seizures, inflammation, viral infection, diabetes, metabolic disorders, free radical excess; Health food supplements; Herb tea for medicinal purposes; Herbal extracts for medical purposes, other than essential oils; Herbal supplements; Herbal tea for medicinal purposes; Liquid herbal supplements; Liquid nutritional supplement; Medicinal roots; Natural herbal supplements; Nutraceuticals for use as a dietary supplement; Nutraceuticals for use as a dietary supplement for treatment of insomnia, sleep disorders, depression, anxiety, neurodegenerative diseases, Alzheimer's disease, dementia, Parkinson's disease, post traumatic stress disorder, phobias, addictions, attention deficit hyperactivity disorder, autism, mood disorders, brain disorders, central nervous system disorders; nutritional supplements for the treatment of neurological diseases, seizures, inflammation, viral infection, diabetes, metabolic disorders, free radical excess; Nutritional supplements; Nutritional supplements consisting primarily of cannabis oil, other than essential oils; Nutritional supplements for treatment of neurological diseases, seizures, inflammation, viral infection, diabetes, metabolic disorders, free radical excess; Nutritional supplements for treatment of insomnia, sleep disorders, depression, anxiety, neurodegenerative diseases, Alzheimer's disease, dementia, Parkinson's disease, post traumatic stress disorder, phobias, addictions, attention deficit hyperactivity disorder, autism, mood disorders, brain disorders, central nervous system disorders; Nutritional supplements in the form of oil other than essential oils, ground seeds, capsules, gelcaps; Nutritional food additives for medical purposes in the nature of natural food extracts derived from cannabis; Plant and herb extracts for medicinal purposes, other than essential oils; Plant and herb extracts for medicinal purposes, other than essential oils, sold as components of medicated cosmetics; Plant extracts for medical, veterinary and pharmaceutical purposes, other than essential oils; Plant extracts for pharmaceutical purposes, other than essential oils; all of the foregoing cannabis-related goods containing cannabis ingredients solely derived from hemp with a delta-9-tetrahydrocannabinol (THC) concentration of not more than 0.3 percent on a dry weight basis and containing no CBD

Classification

International Classes
005